Neurologic clinical trial - RA101495-02.301 (RAISE)

Status:

Start-Up

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Confirm the Safety, Tolerability, and Efficacy of Zilucoplan in Subjects with Generalized Myasthenia Gravis

Drug

Zilucoplan

Condition

Generalized Myasthenia Gravis Myasthenia Gravis

Keywords

Myasthenia Gravis | Ra Pharmaceuticals, Inc.